BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//University of Manitoba//UMFOD Calendar//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:6ad7d33f59bf6@umanitoba.ca
SUMMARY:Part the Cloud Translational Research for Alzheimer’s Disease Program: Combination Therapies Program (PTC-CTP) - Internal Deadline
DESCRIPTION:Part the Cloud Translational Research for Alzheimer’s Disease Program: Combination Therapies Program (PTC-CTP)\n\nThis program will support combination strategies that bring together at least two drug approaches, with optional inclusion of additional drug and or behavioral intervention components, to accelerate innovative, biomarker-informed combination therapies into clinical testing.\n\nEach Phase 2-3 PTC award is limited to a total of $2M USD (direct and indirect costs) for a duration of two to three years. In very rare instances, up to $3M USD may be considered, on a case-by-case basis.\n\nPhase 1 projects are limited to a total of $1M USD total costs. Indirect costs are only allowed for non-profit organizations, and are capped at 10 percent of total direct costs, inclusive of indirect costs for any subcontracts.\n\n\nInternal Application Deadline: Nov 25, 2026 \n\nUMFOD Details: https://research.ad.umanitoba.ca/mrt/pubapp/umfo_view.php?id=4421\n\nProgram URL: https://www.alz.org/research/for_researchers/grants/types-of-grants/part-the-cloud-combination-therapies-program\nInternal Deadline
X-ALT-DESC;FMTTYPE=text/html:<html><body>Part the Cloud Translational Research for Alzheimer’s Disease Program: Combination Therapies Program (PTC-CTP)<br /><br />This program will support combination strategies that bring together at least two drug approaches\, with optional inclusion of additional drug and or behavioral intervention components\, to accelerate innovative\, biomarker-informed combination therapies into clinical testing.<br /><br />Each Phase 2-3 PTC award is limited to a total of $2M USD (direct and indirect costs) for a duration of two to three years. In very rare instances\, up to $3M USD may be considered\, on a case-by-case basis.<br /><br />Phase 1 projects are limited to a total of $1M USD total costs. Indirect costs are only allowed for non-profit organizations\, and are capped at 10 percent of total direct costs\, inclusive of indirect costs for any subcontracts.<br /><br /><br />Internal Application Deadline: Nov 25\, 2026 <br /><br />UMFOD Details: https://research.ad.umanitoba.ca/mrt/pubapp/umfo_view.php?id=4421<br /><br />Program URL: https://www.alz.org/research/for_researchers/grants/types-of-grants/part-the-cloud-combination-therapies-program</body></html>
DTSTART:20261125T083000
DTEND:20261125T093000
BEGIN:VALARM
TRIGGER:-P2D
ACTION:DISPLAY
DESCRIPTION:Reminder for Part the Cloud Translational Research for Alzheimer’s Disease Program: Combination Therapies Program (PTC-CTP)
END:VALARM
END:VEVENT
END:VCALENDAR